Targeting the prostate tumor microenvironment by plant-derived natural products

被引:11
作者
Wu, Jiacheng [1 ,2 ]
Ji, Hao [1 ,2 ]
Li, Tiantian [1 ,2 ]
Guo, Haifeng [1 ,2 ]
Xu, Haifei [1 ,2 ]
Zhu, Jinfeng [1 ,2 ]
Tian, Jiale [1 ,2 ]
Gao, Mingde [1 ,2 ]
Wang, Xiaolin [1 ,2 ]
Zhang, Aihua [2 ,3 ]
机构
[1] Nantong Univ, Affiliated Tumor Hosp, Dept Urol, Nantong 226361, Peoples R China
[2] Nantong Tumor Hosp, Nantong 226361, Peoples R China
[3] Nantong Univ, Operating Room Affiliated Tumor Hosp, Nantong 226361, Peoples R China
关键词
Prostate Cancer; Tumor microenvironment (TME); Natural products; Nanoparticles; CD8+T lymphocytes; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER-ASSOCIATED FIBROBLASTS; IN-VITRO; GROWTH-FACTOR; DRUG-DELIVERY; CELL-PROLIFERATION; ANTITUMOR-ACTIVITY; SUPPRESSOR-CELLS; ORAL DELIVERY; BREAST-CANCER;
D O I
10.1016/j.cellsig.2023.111011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Prostate cancer is among the most common malignancies for men, with limited therapy options for last stages of the tumor. There are some different options for treatment and control of prostate tumor growth. However, targeting some specific molecules and cells within tumors has been attracted interests in recent years. The tumor microenvironment (TME) has an important role in the initiation of various malignancies, which can also expand the progression of tumor and facilitate invasion of malignant cells. By regulating immune responses and distinct changes in the metabolism of cells in the tumor, TME has substantial effects in the resistance of cancer cells to therapy. TME in various solid cancers like prostate cancer includes various cells, including cancer cells, supportive stromal cells, immunosuppressive cells, and anticancer inflammatory cells. Natural products including herbal-derived agents and also other natural compounds have been well studied for their anti-tumor potentials. These compounds may modulate various signaling pathways involved in TME, such as immune responses, the metabolism of cells, epigenetics, angiogenesis, and extracellular matrix (ECM). This paper provides a review of the current knowledge of prostate TME and complex interactions in this environment. Additionally, the potential use of natural products and also nanoparticles loaded with natural products as therapeutic adjuvants on different cells and therapeutic targets within prostate TME will be discussed.
引用
收藏
页数:15
相关论文
共 211 条
[81]   Green nanotechnology of MGF-AuNPs for immunomodulatory intervention in prostate cancer therapy [J].
Khoobchandani, Menka ;
Khan, Aslam ;
Katti, Kavita K. ;
Thipe, Velaphi C. ;
Al-Yasiri, Amal Y. ;
MohanDoss, Darsha K. D. ;
Nicholl, Michael B. ;
Lugao, Ademar B. ;
Hans, Chetan P. ;
Katti, Kattesh V. .
SCIENTIFIC REPORTS, 2021, 11 (01)
[82]   A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells [J].
Kim, Dong Hwan ;
Hossain, Mohammad Akbar ;
Kim, Min Young ;
Kim, Jin-Ah ;
Yoon, Jeong-Hyun ;
Suh, Hong Suk ;
Kim, Gi-Young ;
Choi, Yung Hyun ;
Chung, Hae Young ;
Kim, Nam Deuk .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (06) :1915-1924
[83]   A Drug-Loaded Aptamer-Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer [J].
Kim, Dongkyu ;
Jeong, Yong Yeon ;
Jon, Sangyong .
ACS NANO, 2010, 4 (07) :3689-3696
[84]   The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment [J].
Kim, Seong Keun ;
Cho, Sun Wook .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[85]   Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives [J].
Koinis, Filippos ;
Xagara, Anastasia ;
Chantzara, Evangelia ;
Leontopoulou, Vassiliki ;
Aidarinis, Chrissovalantis ;
Kotsakis, Athanasios .
CELLS, 2022, 11 (01)
[86]   How to select the optimal therapy for early-stage prostate cancer [J].
Kollmeier, Marisa A. ;
Zelefsky, Michael J. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 83 (02) :225-234
[87]   Liposomal paclitaxel formulations [J].
Koudelka, Stepan ;
Turanek, Jaroslav .
JOURNAL OF CONTROLLED RELEASE, 2012, 163 (03) :322-334
[88]  
Kura Y., 2022, Cancer Res., V82, P5952
[89]   Immunomodulatory effects of curcumin monoglucuronide on PD1 immune checkpoint blockade in mouse Pten-null prostate cancer [J].
Kura, Yurie ;
De Velasco, Marco A. ;
Sakai, Kazuko ;
Ando, Naomi ;
Sako, Noriko ;
Fujita, Kazutoshi ;
Banno, Eri ;
Mori, Yasunori ;
Hashimoto, Mamoru ;
Nozawa, Masahiro ;
Yoshimura, Kazuhiro ;
Kakeya, Hideaki ;
Nishio, Kazuto ;
Uemura, Hirotsugu .
CANCER RESEARCH, 2023, 83 (07)
[90]   Unmasking the immune recognition of prostate cancer with CTLA4 blockade [J].
Kwek, Serena S. ;
Cha, Edward ;
Fong, Lawrence .
NATURE REVIEWS CANCER, 2012, 12 (04) :289-297